Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial
The purpose of this study is to evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder.
- Status
- completed
- Phase
- Phase 2
- Institution
- University of Colorado, Denver
- Principal investigator
- Andrew M Novick, MD, PhD
- Start date
- 2024-07-08
- End date
- 2026-05-08
- Registry ID
- NCT06230757
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.